About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04013139

Relationship Between Cardiopulmonary Exercise Testing and Ca-P in Chronic Kidney Disease (CKD)

Reductions in exercise capacity associated with exercise intolerance augment cardiovascular disease risk and predict mortality in chronic kidney disease. This study utilized cardiopulmonary exercise t...

Lead sponsor: Shahid Beheshti University of Medical Sciences•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Shahid Beheshti University of Medical Sciences

Cardiopulmonary exercise testing will carry out in Stage 3-5 chronic kidney disease patients ; estimated glomerular filtration rate \<60 ml/min/1.73 m2) and biochemistry will be added (Ca P Via D PTH FGF23).

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•CKD Patients with GFR \<60 non-dialysis
•age\<18

Exclusion Criteria

•HTN
•not signing consent
•active coronary disease

Related studies

Genetics in the Progression of Nephropathies

NCT06416761 · AKI, CKD, and more

Enrolling By Invitation

Strategies for Proactive Health in People With Kidney Function Decline

NCT07245186 · Renal Insufficiency,Chronic, Dietary Intake Patterns, and more

Effects of Aerobic Versus Resistance Training on Bone Metabolism in Stage 3-4 Chronic Kidney Disease

NCT07133256 · Osteopenia, Bone Metabolism Disorders, and more

Improving Phosphate Control in Children With CKD

NCT05439980 · Chronic Kidney Diseases, Hyperphosphatemia, and more

The Longitudinal PTH-Study

NCT03464149 · CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder, Secondary Hyperparathyroidism, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 28, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment200

Start dateJan 2020

Last updatedJan 28, 2022

Condition

Locations shown

Nooshin Dalili

Tehran

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions